Cancer Breakthroughs, Peptides, and Patents with Cremieux Recueil | 🟡🔴🔵 MTS Live

Cremieux joins MTS to discuss the evolving development and massive popularity of GLP-1 weight loss drugs. He outlines a new AI-designed monoclonal antibody treatment for hair loss and explains how Chinese factories manufacture affordable peptides for the gray market. Finally, Recueil details the retraction of a fraudulent lung cancer study and highlights the promising future of RAS inhibition in oncology--https://x.com/cremieuxrecueil--MTS is a live news and interview show covering technology, business, politics, and culture as it happens.Follow MTS: X | ⁠https://twitter.com/MTSlive⁠YouTube | ⁠https://www.youtube.com/@mtsituation⁠Spotify | ⁠https://open.spotify.com/show/4HUNNmV1pjV7CW6Lphm1rM⁠ Apple | ⁠https://podcasts.apple.com/us/podcast/mts/id1891088763⁠ Substack | ⁠https://mtslive.substack.com/⁠Interested in sponsoring the show? ⁠⁠⁠⁠⁠⁠[email protected]⁠⁠--Brought to you by:Neon (by Databricks) - Get up to $100K in credits for your startup at ⁠https://neon.com/mts⁠ElevenLabs -  AI that communicates at human level across every channel and modality. http://elevenlabs.io/mtsGranola - The AI notepad. Try it once and never go back. https://granola.ai/mtsKong - The AI connectivity platform. Connect APIs, LLMs, agents, and systems with serious security and governance. https://konghq.comBlitzy - Autonomous software development for enterprise codebases. Ship 5x faster. https://blitzy.comMerge - OpenAI, Dropbox, and Ramp use Merge to get AI to production faster. https://merge.dev/mtsAdQuick - Make your brand a billboard. Out-of-home advertising as easy to scale as digital. https://adquick.comMacroscope - AI codebase understanding for engineering leaders. https://macroscope.com/mts--Timestamps:(00:00) Introduction(01:40) People Are Very Slim (05:18) Take Us Through The Arc Here (10:07) Talk To Me About The New Hair Loss Drug (18:18) Why Was It Retracted (25:46) What Is On The Horizon Here --Note: This podcast is not investment, legal, or tax advice, and is intended for informational and entertainment purposes only. Hosts and guests may hold positions in the companies and securities discussed; do your own research before acting on anything you hear.